4 results
Approved WMOWill not start
To evaluate the safety and effectiveness of the BackBeat Moderato system.
Approved WMOCompleted
To study the effect of TRH on opioid-induced respiratory depression in healthy volunteers.
Approved WMOCompleted
The objective of this trial is to show that Ustekinumab is superior to adalimumab as measured by clinical remission after one year of treatment in biologic naïve subjects with moderately-to-severely active CD who have previously failed or were…
Approved WMORecruiting
Primary Objectives (Phase 2 and Phase 3):- To evaluate the clinical efficacy of guselkumab in participants with Crohn*s disease- To evaluate the safety of guselkumabSecondary Objectives:Phase 2:- To evaluate the dose-response of guselkumab to inform…